Avid Bioservices Inc (CDMO)

[volgoat]

The recently completed SUNRISE trial was a randomized phase 3 study of the same combination, but was closed for futility at interim analysis

Funny, NCCN didnt sugar coat it and PPHM paid them $2m to get trials and so far nobody has even applied for the grant?

Specific exclusions from this RFP include:•
Phase 3 studies
Studies in pediatric populations
Studies in unselected immunotherapy
naïve patient populations where
immunotherapy is already approved
(NSCLC,renal cancer, bladder cancer
melanoma)
Combination studies with chemotherapeutic agents;
Single agent studies unless the study is a proposed window study evaluating mechanistic endpoints utilizing multiple tumor biopsies

Studies evaluating bavituximab in combination with pembrolizumab in hepatocellular carcinoma

Proposals focusing solely on preclinical studies

http://cancer.ucsf.edu/intranet/sm_files/NCCN%20Bavituximab%20RFP.pdf